Short Interest in 111, Inc. (NASDAQ:YI) Decreases By 32.7%

111, Inc. (NASDAQ:YI - Get Free Report) saw a large decrease in short interest during the month of May. As of May 31st, there was short interest totalling 3,700 shares, a decrease of 32.7% from the May 15th total of 5,500 shares. Currently, 0.1% of the company's stock are sold short. Based on an average daily trading volume, of 20,000 shares, the short-interest ratio is presently 0.2 days.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a "sell (e+)" rating on shares of 111 in a research report on Wednesday, June 11th.

111 Stock Performance

Shares of YI stock opened at $8.12 on Tuesday. 111 has a 52-week low of $4.15 and a 52-week high of $12.90. The firm has a market capitalization of $70.19 million, a PE ratio of -2.03 and a beta of 0.47. The stock has a fifty day simple moving average of $7.89 and a two-hundred day simple moving average of $7.56.

111 (NASDAQ:YI - Get Free Report) last issued its quarterly earnings data on Thursday, March 20th. The company reported ($0.04) earnings per share for the quarter. The firm had revenue of $527.14 million during the quarter.

Hedge Funds Weigh In On 111

Several institutional investors have recently bought and sold shares of the business. Deuterium Capital Management LLC purchased a new position in 111 in the first quarter worth $81,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in 111 during the first quarter valued at $92,000. JPMorgan Chase & Co. lifted its position in 111 by 43,619.9% during the fourth quarter. JPMorgan Chase & Co. now owns 306,039 shares of the company's stock valued at $191,000 after purchasing an additional 305,339 shares during the period. Napean Trading & Investment Co Singapore PTE Ltd acquired a new position in shares of 111 in the fourth quarter worth about $245,000. Finally, FIL Ltd acquired a new position in shares of 111 in the fourth quarter worth about $450,000. 21.32% of the stock is owned by hedge funds and other institutional investors.

111 Company Profile

111, Inc engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.